The Journal of Organic Chemistry
Article
(NH)). 13C NMR (CDCl3) δ (ppm): 173.2, 158.6, 132.3, 129.2, 113.8,
53.5, 53.1, 51.5, 44.4, 30.9. IR (neat) ν: 2997, 2952, 2835, 1731, 1611,
1511, 1457, 1437, 1243, 1169, 1032, 812 cm−1. HR-MS: mass calcd for
C12H18NO3 [M + H]+ 224.1268, mass measured [M + H]+ 224.1274.
Methyl 3-((3,4-Dimethoxybenzyl)amino)propanoate (29). Pre-
pared according to general method B from 3,4-dimethoxybenzylamine
(1.67 g, 10 mmol) and methyl acrylate (0.86 g, 10 mmol). PSL (50
1.60 (bs(NH)), 1.26 (t, 3H, J = 7.0 Hz). 13C NMR (CDCl3) δ (ppm):
172.8, 158.6, 132.3, 129.2, 113.8, 60.4, 55.3, 53.2, 44.4, 34.8, 14.2. IR
(neat) ν: 2980, 2906, 2835, 1727, 1611, 1511, 1243, 1172, 811 cm−1.
HR-MS: mass calcd for C13H20NO3 [M + H]+ 238.1424, mass
measured [M + H]+ 238.1430.
Ethyl 3-((3,4-Dimethoxybenzyl)amino)propanoate (35). Prepared
according to general method B from 3,4-dimethoxybenzylamine (1.67
g, 10 mmol) and ethyl acrylate (1.0 g, 10 mmol). PSL (50 mg) was
used as catalyst. Yield: 89% (liquid, 2.37 g, 8.9 mmol). 1H NMR
(CDCl3) δ (ppm): 6.84 (m, 3H), 4.14 (q, 2H, J = 7.2 Hz), 3.89 (s,
3H), 3.88 (s, 3H), 3.73 (s, 2H), 2.88 (t, 2H, J = 6.4 Hz), 2.50 (t, 2H, J
= 6.4 Hz), 1.66 (bs(NH)), 1.23 (t, 3H, J = 7.2 Hz). 13C NMR
(CDCl3) δ (ppm): 172.7, 148.9, 147.9, 132.8, 120.0, 111.2, 111.0, 60.3,
55.8, 53.3, 44.5, 34.7, 14.1. IR (neat) ν: 2937, 2906, 2835, 1727, 1514,
1260, 1233, 1155, 1026, 806 cm−1. HR-MS: mass calcd for C14H22NO4
[M + H]+ 268.1530, mass measured [M + H]+ 268.1535.
1
mg) was used as catalyst. Yield: 71% (liquid, 1.88 g, 0.7 mmol) H
NMR (CDCl3) δ (ppm): 6.84 (m, 3H), 3.87 (s, 3H), 3.85 (s, 3H),
3.72 (s, 2H), 3.67 (s, 3H), 2.88 (t, 2H, J = 6.5 Hz), 2.52 (t, 2H, J = 6.4
Hz), 1.67 (bs, (NH)). 13C NMR (CDCl3) δ (ppm): 173.2, 149.0,
148.1 132.8, 120.1, 111.3, 111.1, 55.9, 55.8, 53.5, 51.5, 44.4, 34.5, IR
(neat) ν: 3326.7, 3026, 2951, 2840, 1731, 1453, 1436, 1169, 734, 697
cm−1. HR-MS: mass calcd for C13H20NO4 [M + H]+ 254.1392, mass
measured [M + H]+ 254.1357.
Methyl 3-(Benzylamino)propanoate (3). Prepared according to
general method B from benzylamine (1.07 g, 10 mmol) and
methacrylate (0.86 g, 10 mmol). PSL (50 mg) was used as catalyst.
Ethyl 3-(Benzylamino)propanoate (36). Prepared according to
general method B from benzylamine (1.07g, 10 mmol) and ethyl
acrylate (1.0 g, 10 mmol). PSL (50 mg) was used as catalyst. Yield:
75% (liquid, 1.56 g, 7.5 mmol) 1H NMR (CDCl3) δ (ppm): 7.20 (m,
4H), 7.15 (m, 1H), 4.08 (q, 2H, J = 7.2 Hz), 3.73 (s, 2H), 2.83 (t, 2H,
J = 6.4 Hz), 2.45 (t, 2H, J = 6.4 Hz), 1.58 (bs (NH)), 1.18 (t, 3H, J =
7.2 Hz). 13C NMR (CDCl3) δ (ppm): 172.8, 140.2, 128.4, 128.1,
126.9, 60.4, 53.8, 44.5, 34.8, 14.2. IR (neat) ν: 3327, 3028, 2981, 2906,
2830, 1728, 1175, 1028, 734, 698 cm−1. HR-MS: mass calcd for
C12H18NO2 [M + H]+ 208.1332, mass measured [M + H]+ 208.1326.
Ethyl 3-(2-Phenylethylamino)propanoate (37). Prepared accord-
ing to general method B from 2-phenylethylamine (1.09 g, 10 mmol)
and ethyl acrylate (1.0 g, 10 mmol). PSL (50 mg) was used as catalyst.
1
Yield: 78% (liquid, 1.51 g, 7.8 mmol). H NMR (CDCl3) δ (ppm):
7.22 (m, 5H), 3.77 (s, 2H), 3.64 (s, 3H), 2.87 (t, 2H, J = 6.5 Hz), 2.50
(t, 2H, J = 6.5 Hz), 1.75 (bs, (NH)). 13C NMR (CDCl3) δ (ppm):
173.1, 140.2, 128.4, 128.0, 126.9, 53.7, 51.5, 44.5, 34.6. IR (neat) ν:
3326.7, 3026, 2951, 2840, 1731, 1453, 1436, 1169.5, 734, 697 cm−1.
HR-MS: mass calcd for C11H16NO2 [M + H]+ 194.1176, mass
measured [M + H]+ 194.1169.
Ethyl 3-(Piperidin-1-yl)propanoate (30). Prepared according to
general method B from piperazine (0.86 g, 10 mmol) and ethyl
acrylate (1.0 g, 10 mmol). PSL (50 mg) was used as catalyst. Yield:
1
95% (liquid, 1.75 g, 9.5 mmol). H NMR (CDCl3) δ (ppm): 4.07 (q,
1
2H, J = 7.5 Hz), 2.59 (t, 2H, J = 7.5 Hz), 2.44 (t, 2H, J = 7.6 Hz), 2.34
(m, 4H), 1.50 (m, 4H), 1.36 (m, 2H), 1.20 (t, 3H, J = 7.5 Hz). 13C
NMR (CDCl3) 172.8, 60.3, 54.3, 54.2, 32.3, 25.9, 24.3, 14.2. IR (neat)
ν: 2980, 2934, 2853, 1734, 1171, 1153, 1075 cm−1. HR-MS: mass
calcd for C10H20NO2 [M + H]+ 186.1489, mass measured [M + H]+
186.1482.
Yield: 70% (liquid, 1.55 g, 7.1 mmol). H NMR (CDCl3) δ (ppm):
7.21 (m, 5H), 4.08 (q, 2H, J = 6.5 Hz), 2.87 (m, 4H), 2.70 (t, 2H, J =
7.5 Hz), 2.44 (t, 2H, J = 7.5 Hz), 1.51 (bs, 1H, (NH)) 1.21 (t, 3H, J =
6.5 Hz). 13C NMR (CDCl3) δ (ppm): 172.4, 139.8, 128.5, 125.9, 60.1,
50.8, 44.1, 36.2, 34.6, 14.0. IR (neat) ν: 3027, 2974, 2950, 2829, 1731,
1495, 1255, 1194, 735, 698 cm−1. HR-MS: mass calcd for C14H22NO2
[M + H]+ 222.1494, mass measured [M + H]+ 222.1498.
Ethyl 3-Morpholinopropanoate (31). Prepared according to
general method B from morpholine (0.87 g, 10 mmol) and ethyl
acrylate (1.0 g, 10 mmol). PSL (50 mg) was used as catalyst. Yield:
Butyl 3-(Piperidin-1-yl)propanoate (38). Prepared according to
general method B from piperidine (0.85 g, 10 mmol) and butyl
acrylate (1.28 g, 10 mmol). PSL (50 mg) was used as a catalyst. Yield:
1
95% (liquid, 9.5 mmol, 1.77 g). H NMR (CDCl3) δ (ppm): 4.07 (q,
1
2H, J = 7.5 Hz), 3.62 (m, 4H), 2.62 (t, 2H, J = 7.5 Hz), 2.5−2.3 (m,
6H), 1.19 (t, 3H, J = 7.5 Hz). 13C NMR (CDCl3) δ (ppm): 174.7,
69.2, 62.7, 56.3, 55.7, 34.5, 16.5. IR (neat) ν: 2958, 2854, 2810, 1731,
1255, 1185, 1115, 1010 cm−1. HR-MS: mass calcd for C9H18NO3 [M
+ H]+ 188.1281, mass measured [M + H]+ 188.1276.
94% (liquid, 2.00 g, 9.4 mmol). H NMR (CDCl3) δ (ppm): 4.01 (t,
2H, J = 6.6 Hz), 2.61 (t, 2H, J = 7.4 Hz), 2.42 (t, 2H, J = 7.4 Hz), 2.32
(m, 4H), 1.54 (m, 6H), 1.35 (m, 4H), 0.86 (t, 3H, J = 8.6 Hz). 13C
NMR (CDCl3) δ (ppm): 172.8, 64.2, 54.3, 54.2, 32.4, 30.7, 25.9, 24.3,
19.1, 13.7. IR (neat) ν: 2934, 2855, 2776, 1735, 1170, 1153, 1114
cm−1. HR-MS: mass calcd for C12H24NO2 [M + H]+ 214.1788, mass
measured [M + H]+ 214.1794.
Ethyl 3-(4-Methylpiperazin-1-yl)propanoate (32). Prepared ac-
cording to general method B from 1-methylpiperazine (1.0 g, 10
mmol) and ethyl acrylate (1.0 g, 10 mmol). PSL (50 mg) was used as
Butyl 3-Morpholinopropanoate (39). Prepared according to
general method B from morpholine (0.87 g, 10 mmol) and butyl
acrylate (1.28 g, 10 mmol). PSL (50 mg) was used as catalyst. Yield:
1
catalyst. Yield: 95% (liquid, 1.90 g, 9.5 mmol). H NMR (CDCl3) δ
(ppm): 4.14 (q, 2H, J = 7.0 Hz), 2.70 (t, 2H, J = 7.0 Hz), 2.5−2.4 (m,
10H), 2.28 (s, 3H), 1.25 (t, 3H, J = 7.0 Hz). 13C NMR (CDCl3) δ
(ppm): 172.5, 60.3, 55.1, 53.5, 52.8, 46.0, 32.3, 14.2. IR (neat) ν: 2938,
2879, 2794, 1733, 1459, 1284, 1180, 1162, 1027 cm−1. HR-MS: mass
calcd for C10H21N2O2 [M + H]+ 201.1598, mass measured [M + H]+
201.1593.
1
90% (liquid, 1.93 g, 9.0 mmol). H NMR (CDCl3) δ (ppm): 4.02 (t,
2H, J = 7.0 Hz), 3.62 (m, 4H), 2.61 (t, 2H, J = 7.5 Hz), 2.46 (t, 2H, J =
7.5 Hz) 2.44 (m, 4H), 1. 57 (m, 2H), 1.34 (m, 2H), 0.87 (t, 3H, J =
7.6 Hz). 13C NMR (CDCl3) 172.4, 66.9, 64.3, 54.0, 53.4, 32.2, 30.7,
19.1, 13.7. IR (neat) ν: 2958, 2855, 2810, 1733, 1458, 1116, 1035, 868,
859 cm−1. HR-MS: mass calcd for C11H22NO3 [M + H]+ 216.1594,
mass measured [M + H]+ 216.1588.
Ethyl 3-(Allylamino)propanoate (33). Prepared according to
general method B from allylamine (0.57 g, 10 mmol) and ethyl
acrylate (1.0 g, 10 mmol). PSL (50 mg) was used as catalyst. Yield:
Butyl 3-(4-Methylpiperazin-1-yl)propanoate (40). Prepared ac-
cording to general method B from 1-methylpiperazine (1.00 g, 10
mmol) and butyl acrylate (1.28 g, 10 mmol). PSL (50 mg) was used as
1
n.d. H NMR (CDCl3) δ (ppm): 5.90 (sm, 1H), 5.16 (m, 2H), 4.15
(q, 2H, J = 7.2 Hz), 3.27 (dt, J = 6.0, J = 1.5 Hz, 2H), 2.88 (t, 2H, J =
6.6 Hz), 2.50 (t, 2H, J = 6.6 Hz), 1.53 (bs, (NH)), 1.27 (t, 3H, J = 7.2
Hz). 13C NMR (CDCl3) δ (ppm): 172.7, 136.7, 115.9, 60.4, 52.2, 44.4,
34.8, 14.2. IR (neat) ν: 3362, 3079, 2981, 2907, 2825, 1729, 1459,
1417, 1179 cm−1. HR-MS: mass calcd for C8H16NO2 [M + H]+
158.1176, mass measured [M + H]+ 158.1170.
Ethyl 3-((4-Methoxybenzyl)amino)propanoate (34). Prepared
according to general method B from 4-methoxybenzylamine (1.37 g,
10 mmol) and ethyl acrylate (1.0 g, 10 mmol). PSL (50 mg) was used
as catalyst. Yield: 71% (liquid, 1.68 g, 7.1 mmol). 1H NMR (CDCl3) δ
(ppm): 7.24 (m, 2H), 6.87 (m, 2H), 4.14 (q, 2H, J = 7.0 Hz), 3.80 (s,
3H), 3.74 (s, 2H), 2.89 (t, 2H, J = 6.4 Hz), 2.52 (t, 2H, J = 6.4 Hz),
1
catalyst. Yield: 95% (liquid, 2.17 g, 9.5 mmol). H NMR (CDCl3) δ
(ppm): 4.09 (t, 2H, J = 6.6 Hz), 2.71 (t, 2H, J = 6.8 Hz), 2.51−2.36
(m, 10H), 2.28 (s, 3H), 1.64−1.57 (m, 2H), 1.43−1.33 (m, 2H), 0.94
(t, 3H, J = 7.2 Hz). 13C NMR (CDCl3) δ (ppm): 172.6, 64.3, 55.1,
53.6, 52.9, 46.0, 32.4, 30.7, 19.1, 13.7. IR (neat) ν: 2936, 2794, 1734,
1458, 1178, 1013 cm−1. HR-MS: mass calcd for C12H25N2O2 [M +
H]+ 229.1916, mass measured [M + H]+ 229.1908.
Butyl 3-(Allylamino)propanoate (41). Prepared according to
general method B from allylamine (0.57 g, 10 mmol) and butyl
acrylate (1.28 g, 10 mmol). PSL (50 mg) was used as a catalyst. Yield:
19% (liquid, 0.35 g, 1.9 mmol). 1H NMR (CDCl3) δ (ppm): 5.83 (sm,
3811
dx.doi.org/10.1021/jo400268u | J. Org. Chem. 2013, 78, 3802−3813